Daxor has received approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656. The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body. Albumin is the major carrier molecule in the human body for […]
New York, NY April 6, 2016 Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announces the first interventional outcomes data to be presented in heart failure patients receiving individualized care guided by direct blood volume analysis (BVA). The data were presented at the American College of Cardiology congress by John […]
New York, NY March 9, 2016 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announces a study on critically ill patients utilizing blood volume measurement and pulmonary artery catheterization (PAC). Pulmonary artery catheterization, an invasive procedure, involves threading a catheter into the heart to measure pressures. Millions of […]
The BVA-100 is the first FDA Approved machine to accurately measure blood volume in as little as 30 minutes. Review our product literature to learn more.